FRONT NEUROL 润色咨询

Frontiers in Neurology

出版年份：2014 年文章数：10200 投稿命中率： 开通期刊会员，数据随心看

出版周期：Irregular 自引率：6.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1189945, encodeId=0d42118994528, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：stroke<br>经验分享：2021年12月中旬就已经review finalized了，最后提交完修改意见，一直处于editor is evaluating阶段，毫无进展，中间发过一次邮件，编辑没有回，怎么办阿？需要给总编辑部发邮件问问嘛，希望有经验的朋友支个招，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e385414305, createdName=ms1000001473869572, createdTime=Thu Feb 03 17:08:56 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977098, encodeId=ae289e7098cd, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>经验分享：2.20投稿，找编辑找了2个礼拜，5.6 interactive review，中修，5.14提交全部审稿意见，5.24三个审稿人全部endorsed，神奇的事情来了，5.13 编辑撂挑子不干了，找新编辑倒是挺快，5.23换了个大佬，但是新编辑不知道在干嘛，愣是拖了一个月，狂发邮件催，6.24编辑部介入，6.24 accepted,现在在等proof。所以说还是要多催催，编辑和编辑部一起催才有效果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cea5534804, createdName=DonAlexander, createdTime=Sat Jun 26 17:46:40 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑<br>7.13 Reviewer 1 is finalized.5555<br>7.26 Reviewer 2审完以后退出审稿3222<br>8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322<br>现在在第4个审稿人手里<br>这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192389, encodeId=d0bd1192389bc, content=偏重的研究方向：卒中;脑卒中<br>经验分享：之前审稿人1拒绝，审稿人3同意，审稿人2没做最终决定，然后编辑给了我时间大修，提交修改后，现在审稿人2也endorse了，希望大不，各位大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=周云祥, createdTime=Fri Feb 11 17:12:07 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101333, encodeId=5b8f2101333e0, content=什么时候中科院分区能到2区就好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJElIu4hBWdtKsL8e4OMFX4blMPokTQfJmF9xxjj6icsFK3wjhEtUYhh32DcBtw9jbEldHI9Yl5icoA/132, createdBy=f7322516953, createdName=钧钧, createdTime=Fri Nov 18 14:22:43 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. <br>09 May 2022 Review of Reviewer 4 is finalized. <br>05 May 2022 Interactive review forum activated automatically. <br>01 May 2022 Review of Reviewer 2 is finalized. <br>27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060422, encodeId=303f1060422b9, content=投的frontiers in oncology 洗个澡，后编辑让转投frontiers in neurology ，请问这个杂志好中吗，速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/18/3624dd53d07dd836b207284f6fb6cc08.jpg, createdBy=b9932459487, createdName=1241475am06暂无昵称, createdTime=Thu Oct 14 12:24:41 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813438, encodeId=913e81343879, content=第一次大修后，审稿人二同意发表，审稿人一不同意（而且语气说的很强硬），又给了一个礼拜让修改，修改完过了16天了，还没信，是不是要完了啊，哭死了！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42985413445, createdName=ms7000000171990402, createdTime=Wed Aug 26 15:03:57 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224799, encodeId=39841224e99d4, content=一审，审稿人3endorse，审稿人1和审稿人2让修改，修回去10天了，审稿人1回复修改挺满意，但没给finalized，审稿人2一直没回复，焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45895697468, createdName=ms8000001636492834, createdTime=Mon Jun 06 19:26:12 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588861, encodeId=cad8588861f8, content=3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回 目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]
    2022-02-03 ms1000001473869572

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向：stroke
    经验分享：2021年12月中旬就已经review finalized了，最后提交完修改意见，一直处于editor is evaluating阶段，毫无进展，中间发过一次邮件，编辑没有回，怎么办阿？需要给总编辑部发邮件问问嘛，希望有经验的朋友支个招，谢谢

    12

    展开12条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1189945, encodeId=0d42118994528, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：stroke<br>经验分享：2021年12月中旬就已经review finalized了，最后提交完修改意见，一直处于editor is evaluating阶段，毫无进展，中间发过一次邮件，编辑没有回，怎么办阿？需要给总编辑部发邮件问问嘛，希望有经验的朋友支个招，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e385414305, createdName=ms1000001473869572, createdTime=Thu Feb 03 17:08:56 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977098, encodeId=ae289e7098cd, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>经验分享：2.20投稿，找编辑找了2个礼拜，5.6 interactive review，中修，5.14提交全部审稿意见，5.24三个审稿人全部endorsed，神奇的事情来了，5.13 编辑撂挑子不干了，找新编辑倒是挺快，5.23换了个大佬，但是新编辑不知道在干嘛，愣是拖了一个月，狂发邮件催，6.24编辑部介入，6.24 accepted,现在在等proof。所以说还是要多催催，编辑和编辑部一起催才有效果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cea5534804, createdName=DonAlexander, createdTime=Sat Jun 26 17:46:40 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑<br>7.13 Reviewer 1 is finalized.5555<br>7.26 Reviewer 2审完以后退出审稿3222<br>8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322<br>现在在第4个审稿人手里<br>这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192389, encodeId=d0bd1192389bc, content=偏重的研究方向：卒中;脑卒中<br>经验分享：之前审稿人1拒绝，审稿人3同意，审稿人2没做最终决定，然后编辑给了我时间大修，提交修改后，现在审稿人2也endorse了，希望大不，各位大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=周云祥, createdTime=Fri Feb 11 17:12:07 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101333, encodeId=5b8f2101333e0, content=什么时候中科院分区能到2区就好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJElIu4hBWdtKsL8e4OMFX4blMPokTQfJmF9xxjj6icsFK3wjhEtUYhh32DcBtw9jbEldHI9Yl5icoA/132, createdBy=f7322516953, createdName=钧钧, createdTime=Fri Nov 18 14:22:43 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. <br>09 May 2022 Review of Reviewer 4 is finalized. <br>05 May 2022 Interactive review forum activated automatically. <br>01 May 2022 Review of Reviewer 2 is finalized. <br>27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060422, encodeId=303f1060422b9, content=投的frontiers in oncology 洗个澡，后编辑让转投frontiers in neurology ，请问这个杂志好中吗，速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/18/3624dd53d07dd836b207284f6fb6cc08.jpg, createdBy=b9932459487, createdName=1241475am06暂无昵称, createdTime=Thu Oct 14 12:24:41 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813438, encodeId=913e81343879, content=第一次大修后，审稿人二同意发表，审稿人一不同意（而且语气说的很强硬），又给了一个礼拜让修改，修改完过了16天了，还没信，是不是要完了啊，哭死了！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42985413445, createdName=ms7000000171990402, createdTime=Wed Aug 26 15:03:57 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224799, encodeId=39841224e99d4, content=一审，审稿人3endorse，审稿人1和审稿人2让修改，修回去10天了，审稿人1回复修改挺满意，但没给finalized，审稿人2一直没回复，焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45895697468, createdName=ms8000001636492834, createdTime=Mon Jun 06 19:26:12 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588861, encodeId=cad8588861f8, content=3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回 目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]
    2021-06-26 DonAlexander

    审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:2950.0
    经验分享：2.20投稿，找编辑找了2个礼拜，5.6 interactive review，中修，5.14提交全部审稿意见，5.24三个审稿人全部endorsed，神奇的事情来了，5.13 编辑撂挑子不干了，找新编辑倒是挺快，5.23换了个大佬，但是新编辑不知道在干嘛，愣是拖了一个月，狂发邮件催，6.24编辑部介入，6.24 accepted,现在在等proof。所以说还是要多催催，编辑和编辑部一起催才有效果

    8

    展开8条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1189945, encodeId=0d42118994528, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：stroke<br>经验分享：2021年12月中旬就已经review finalized了，最后提交完修改意见，一直处于editor is evaluating阶段，毫无进展，中间发过一次邮件，编辑没有回，怎么办阿？需要给总编辑部发邮件问问嘛，希望有经验的朋友支个招，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e385414305, createdName=ms1000001473869572, createdTime=Thu Feb 03 17:08:56 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977098, encodeId=ae289e7098cd, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>经验分享：2.20投稿，找编辑找了2个礼拜，5.6 interactive review，中修，5.14提交全部审稿意见，5.24三个审稿人全部endorsed，神奇的事情来了，5.13 编辑撂挑子不干了，找新编辑倒是挺快，5.23换了个大佬，但是新编辑不知道在干嘛，愣是拖了一个月，狂发邮件催，6.24编辑部介入，6.24 accepted,现在在等proof。所以说还是要多催催，编辑和编辑部一起催才有效果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cea5534804, createdName=DonAlexander, createdTime=Sat Jun 26 17:46:40 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑<br>7.13 Reviewer 1 is finalized.5555<br>7.26 Reviewer 2审完以后退出审稿3222<br>8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322<br>现在在第4个审稿人手里<br>这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192389, encodeId=d0bd1192389bc, content=偏重的研究方向：卒中;脑卒中<br>经验分享：之前审稿人1拒绝，审稿人3同意，审稿人2没做最终决定，然后编辑给了我时间大修，提交修改后，现在审稿人2也endorse了，希望大不，各位大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=周云祥, createdTime=Fri Feb 11 17:12:07 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101333, encodeId=5b8f2101333e0, content=什么时候中科院分区能到2区就好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJElIu4hBWdtKsL8e4OMFX4blMPokTQfJmF9xxjj6icsFK3wjhEtUYhh32DcBtw9jbEldHI9Yl5icoA/132, createdBy=f7322516953, createdName=钧钧, createdTime=Fri Nov 18 14:22:43 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. <br>09 May 2022 Review of Reviewer 4 is finalized. <br>05 May 2022 Interactive review forum activated automatically. <br>01 May 2022 Review of Reviewer 2 is finalized. <br>27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060422, encodeId=303f1060422b9, content=投的frontiers in oncology 洗个澡，后编辑让转投frontiers in neurology ，请问这个杂志好中吗，速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/18/3624dd53d07dd836b207284f6fb6cc08.jpg, createdBy=b9932459487, createdName=1241475am06暂无昵称, createdTime=Thu Oct 14 12:24:41 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813438, encodeId=913e81343879, content=第一次大修后，审稿人二同意发表，审稿人一不同意（而且语气说的很强硬），又给了一个礼拜让修改，修改完过了16天了，还没信，是不是要完了啊，哭死了！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42985413445, createdName=ms7000000171990402, createdTime=Wed Aug 26 15:03:57 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224799, encodeId=39841224e99d4, content=一审，审稿人3endorse，审稿人1和审稿人2让修改，修回去10天了，审稿人1回复修改挺满意，但没给finalized，审稿人2一直没回复，焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45895697468, createdName=ms8000001636492834, createdTime=Mon Jun 06 19:26:12 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588861, encodeId=cad8588861f8, content=3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回 目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]
    2022-08-19 Yhao

    7.6分配编辑
    7.13 Reviewer 1 is finalized.5555
    7.26 Reviewer 2审完以后退出审稿3222
    8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322
    现在在第4个审稿人手里
    这啥情况啊？

    7

    展开7条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1189945, encodeId=0d42118994528, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：stroke<br>经验分享：2021年12月中旬就已经review finalized了，最后提交完修改意见，一直处于editor is evaluating阶段，毫无进展，中间发过一次邮件，编辑没有回，怎么办阿？需要给总编辑部发邮件问问嘛，希望有经验的朋友支个招，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e385414305, createdName=ms1000001473869572, createdTime=Thu Feb 03 17:08:56 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977098, encodeId=ae289e7098cd, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>经验分享：2.20投稿，找编辑找了2个礼拜，5.6 interactive review，中修，5.14提交全部审稿意见，5.24三个审稿人全部endorsed，神奇的事情来了，5.13 编辑撂挑子不干了，找新编辑倒是挺快，5.23换了个大佬，但是新编辑不知道在干嘛，愣是拖了一个月，狂发邮件催，6.24编辑部介入，6.24 accepted,现在在等proof。所以说还是要多催催，编辑和编辑部一起催才有效果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cea5534804, createdName=DonAlexander, createdTime=Sat Jun 26 17:46:40 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑<br>7.13 Reviewer 1 is finalized.5555<br>7.26 Reviewer 2审完以后退出审稿3222<br>8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322<br>现在在第4个审稿人手里<br>这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192389, encodeId=d0bd1192389bc, content=偏重的研究方向：卒中;脑卒中<br>经验分享：之前审稿人1拒绝，审稿人3同意，审稿人2没做最终决定，然后编辑给了我时间大修，提交修改后，现在审稿人2也endorse了，希望大不，各位大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=周云祥, createdTime=Fri Feb 11 17:12:07 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101333, encodeId=5b8f2101333e0, content=什么时候中科院分区能到2区就好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJElIu4hBWdtKsL8e4OMFX4blMPokTQfJmF9xxjj6icsFK3wjhEtUYhh32DcBtw9jbEldHI9Yl5icoA/132, createdBy=f7322516953, createdName=钧钧, createdTime=Fri Nov 18 14:22:43 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. <br>09 May 2022 Review of Reviewer 4 is finalized. <br>05 May 2022 Interactive review forum activated automatically. <br>01 May 2022 Review of Reviewer 2 is finalized. <br>27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060422, encodeId=303f1060422b9, content=投的frontiers in oncology 洗个澡，后编辑让转投frontiers in neurology ，请问这个杂志好中吗，速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/18/3624dd53d07dd836b207284f6fb6cc08.jpg, createdBy=b9932459487, createdName=1241475am06暂无昵称, createdTime=Thu Oct 14 12:24:41 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813438, encodeId=913e81343879, content=第一次大修后，审稿人二同意发表，审稿人一不同意（而且语气说的很强硬），又给了一个礼拜让修改，修改完过了16天了，还没信，是不是要完了啊，哭死了！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42985413445, createdName=ms7000000171990402, createdTime=Wed Aug 26 15:03:57 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224799, encodeId=39841224e99d4, content=一审，审稿人3endorse，审稿人1和审稿人2让修改，修回去10天了，审稿人1回复修改挺满意，但没给finalized，审稿人2一直没回复，焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45895697468, createdName=ms8000001636492834, createdTime=Mon Jun 06 19:26:12 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588861, encodeId=cad8588861f8, content=3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回 目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]
    2022-02-11 周云祥

    偏重的研究方向：卒中;脑卒中
    经验分享：之前审稿人1拒绝，审稿人3同意，审稿人2没做最终决定，然后编辑给了我时间大修，提交修改后，现在审稿人2也endorse了，希望大不，各位大佬们

    6

    展开6条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1189945, encodeId=0d42118994528, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：stroke<br>经验分享：2021年12月中旬就已经review finalized了，最后提交完修改意见，一直处于editor is evaluating阶段，毫无进展，中间发过一次邮件，编辑没有回，怎么办阿？需要给总编辑部发邮件问问嘛，希望有经验的朋友支个招，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e385414305, createdName=ms1000001473869572, createdTime=Thu Feb 03 17:08:56 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977098, encodeId=ae289e7098cd, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>经验分享：2.20投稿，找编辑找了2个礼拜，5.6 interactive review，中修，5.14提交全部审稿意见，5.24三个审稿人全部endorsed，神奇的事情来了，5.13 编辑撂挑子不干了，找新编辑倒是挺快，5.23换了个大佬，但是新编辑不知道在干嘛，愣是拖了一个月，狂发邮件催，6.24编辑部介入，6.24 accepted,现在在等proof。所以说还是要多催催，编辑和编辑部一起催才有效果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cea5534804, createdName=DonAlexander, createdTime=Sat Jun 26 17:46:40 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑<br>7.13 Reviewer 1 is finalized.5555<br>7.26 Reviewer 2审完以后退出审稿3222<br>8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322<br>现在在第4个审稿人手里<br>这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192389, encodeId=d0bd1192389bc, content=偏重的研究方向：卒中;脑卒中<br>经验分享：之前审稿人1拒绝，审稿人3同意，审稿人2没做最终决定，然后编辑给了我时间大修，提交修改后，现在审稿人2也endorse了，希望大不，各位大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=周云祥, createdTime=Fri Feb 11 17:12:07 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101333, encodeId=5b8f2101333e0, content=什么时候中科院分区能到2区就好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJElIu4hBWdtKsL8e4OMFX4blMPokTQfJmF9xxjj6icsFK3wjhEtUYhh32DcBtw9jbEldHI9Yl5icoA/132, createdBy=f7322516953, createdName=钧钧, createdTime=Fri Nov 18 14:22:43 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. <br>09 May 2022 Review of Reviewer 4 is finalized. <br>05 May 2022 Interactive review forum activated automatically. <br>01 May 2022 Review of Reviewer 2 is finalized. <br>27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060422, encodeId=303f1060422b9, content=投的frontiers in oncology 洗个澡，后编辑让转投frontiers in neurology ，请问这个杂志好中吗，速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/18/3624dd53d07dd836b207284f6fb6cc08.jpg, createdBy=b9932459487, createdName=1241475am06暂无昵称, createdTime=Thu Oct 14 12:24:41 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813438, encodeId=913e81343879, content=第一次大修后，审稿人二同意发表，审稿人一不同意（而且语气说的很强硬），又给了一个礼拜让修改，修改完过了16天了，还没信，是不是要完了啊，哭死了！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42985413445, createdName=ms7000000171990402, createdTime=Wed Aug 26 15:03:57 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224799, encodeId=39841224e99d4, content=一审，审稿人3endorse，审稿人1和审稿人2让修改，修回去10天了，审稿人1回复修改挺满意，但没给finalized，审稿人2一直没回复，焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45895697468, createdName=ms8000001636492834, createdTime=Mon Jun 06 19:26:12 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588861, encodeId=cad8588861f8, content=3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回 目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]
    2022-11-18 钧钧

    什么时候中科院分区能到2区就好了

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1189945, encodeId=0d42118994528, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：stroke<br>经验分享：2021年12月中旬就已经review finalized了，最后提交完修改意见，一直处于editor is evaluating阶段，毫无进展，中间发过一次邮件，编辑没有回，怎么办阿？需要给总编辑部发邮件问问嘛，希望有经验的朋友支个招，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e385414305, createdName=ms1000001473869572, createdTime=Thu Feb 03 17:08:56 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977098, encodeId=ae289e7098cd, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>经验分享：2.20投稿，找编辑找了2个礼拜，5.6 interactive review，中修，5.14提交全部审稿意见，5.24三个审稿人全部endorsed，神奇的事情来了，5.13 编辑撂挑子不干了，找新编辑倒是挺快，5.23换了个大佬，但是新编辑不知道在干嘛，愣是拖了一个月，狂发邮件催，6.24编辑部介入，6.24 accepted,现在在等proof。所以说还是要多催催，编辑和编辑部一起催才有效果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cea5534804, createdName=DonAlexander, createdTime=Sat Jun 26 17:46:40 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑<br>7.13 Reviewer 1 is finalized.5555<br>7.26 Reviewer 2审完以后退出审稿3222<br>8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322<br>现在在第4个审稿人手里<br>这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192389, encodeId=d0bd1192389bc, content=偏重的研究方向：卒中;脑卒中<br>经验分享：之前审稿人1拒绝，审稿人3同意，审稿人2没做最终决定，然后编辑给了我时间大修，提交修改后，现在审稿人2也endorse了，希望大不，各位大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=周云祥, createdTime=Fri Feb 11 17:12:07 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101333, encodeId=5b8f2101333e0, content=什么时候中科院分区能到2区就好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJElIu4hBWdtKsL8e4OMFX4blMPokTQfJmF9xxjj6icsFK3wjhEtUYhh32DcBtw9jbEldHI9Yl5icoA/132, createdBy=f7322516953, createdName=钧钧, createdTime=Fri Nov 18 14:22:43 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. <br>09 May 2022 Review of Reviewer 4 is finalized. <br>05 May 2022 Interactive review forum activated automatically. <br>01 May 2022 Review of Reviewer 2 is finalized. <br>27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060422, encodeId=303f1060422b9, content=投的frontiers in oncology 洗个澡，后编辑让转投frontiers in neurology ，请问这个杂志好中吗，速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/18/3624dd53d07dd836b207284f6fb6cc08.jpg, createdBy=b9932459487, createdName=1241475am06暂无昵称, createdTime=Thu Oct 14 12:24:41 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813438, encodeId=913e81343879, content=第一次大修后，审稿人二同意发表，审稿人一不同意（而且语气说的很强硬），又给了一个礼拜让修改，修改完过了16天了，还没信，是不是要完了啊，哭死了！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42985413445, createdName=ms7000000171990402, createdTime=Wed Aug 26 15:03:57 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224799, encodeId=39841224e99d4, content=一审，审稿人3endorse，审稿人1和审稿人2让修改，修回去10天了，审稿人1回复修改挺满意，但没给finalized，审稿人2一直没回复，焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45895697468, createdName=ms8000001636492834, createdTime=Mon Jun 06 19:26:12 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588861, encodeId=cad8588861f8, content=3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回 目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]
    2022-05-17 ms8000001327218017

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments.
    09 May 2022 Review of Reviewer 4 is finalized.
    05 May 2022 Interactive review forum activated automatically.
    01 May 2022 Review of Reviewer 2 is finalized.
    27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。

    5

    展开5条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1189945, encodeId=0d42118994528, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：stroke<br>经验分享：2021年12月中旬就已经review finalized了，最后提交完修改意见，一直处于editor is evaluating阶段，毫无进展，中间发过一次邮件，编辑没有回，怎么办阿？需要给总编辑部发邮件问问嘛，希望有经验的朋友支个招，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e385414305, createdName=ms1000001473869572, createdTime=Thu Feb 03 17:08:56 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977098, encodeId=ae289e7098cd, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>经验分享：2.20投稿，找编辑找了2个礼拜，5.6 interactive review，中修，5.14提交全部审稿意见，5.24三个审稿人全部endorsed，神奇的事情来了，5.13 编辑撂挑子不干了，找新编辑倒是挺快，5.23换了个大佬，但是新编辑不知道在干嘛，愣是拖了一个月，狂发邮件催，6.24编辑部介入，6.24 accepted,现在在等proof。所以说还是要多催催，编辑和编辑部一起催才有效果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cea5534804, createdName=DonAlexander, createdTime=Sat Jun 26 17:46:40 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑<br>7.13 Reviewer 1 is finalized.5555<br>7.26 Reviewer 2审完以后退出审稿3222<br>8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322<br>现在在第4个审稿人手里<br>这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192389, encodeId=d0bd1192389bc, content=偏重的研究方向：卒中;脑卒中<br>经验分享：之前审稿人1拒绝，审稿人3同意，审稿人2没做最终决定，然后编辑给了我时间大修，提交修改后，现在审稿人2也endorse了，希望大不，各位大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=周云祥, createdTime=Fri Feb 11 17:12:07 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101333, encodeId=5b8f2101333e0, content=什么时候中科院分区能到2区就好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJElIu4hBWdtKsL8e4OMFX4blMPokTQfJmF9xxjj6icsFK3wjhEtUYhh32DcBtw9jbEldHI9Yl5icoA/132, createdBy=f7322516953, createdName=钧钧, createdTime=Fri Nov 18 14:22:43 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. <br>09 May 2022 Review of Reviewer 4 is finalized. <br>05 May 2022 Interactive review forum activated automatically. <br>01 May 2022 Review of Reviewer 2 is finalized. <br>27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060422, encodeId=303f1060422b9, content=投的frontiers in oncology 洗个澡，后编辑让转投frontiers in neurology ，请问这个杂志好中吗，速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/18/3624dd53d07dd836b207284f6fb6cc08.jpg, createdBy=b9932459487, createdName=1241475am06暂无昵称, createdTime=Thu Oct 14 12:24:41 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813438, encodeId=913e81343879, content=第一次大修后，审稿人二同意发表，审稿人一不同意（而且语气说的很强硬），又给了一个礼拜让修改，修改完过了16天了，还没信，是不是要完了啊，哭死了！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42985413445, createdName=ms7000000171990402, createdTime=Wed Aug 26 15:03:57 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224799, encodeId=39841224e99d4, content=一审，审稿人3endorse，审稿人1和审稿人2让修改，修回去10天了，审稿人1回复修改挺满意，但没给finalized，审稿人2一直没回复，焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45895697468, createdName=ms8000001636492834, createdTime=Mon Jun 06 19:26:12 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588861, encodeId=cad8588861f8, content=3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回 目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]
    2021-10-14 1241475am06暂无昵称

    投的frontiers in oncology 洗个澡，后编辑让转投frontiers in neurology ，请问这个杂志好中吗，速度快吗

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1189945, encodeId=0d42118994528, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：stroke<br>经验分享：2021年12月中旬就已经review finalized了，最后提交完修改意见，一直处于editor is evaluating阶段，毫无进展，中间发过一次邮件，编辑没有回，怎么办阿？需要给总编辑部发邮件问问嘛，希望有经验的朋友支个招，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e385414305, createdName=ms1000001473869572, createdTime=Thu Feb 03 17:08:56 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977098, encodeId=ae289e7098cd, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>经验分享：2.20投稿，找编辑找了2个礼拜，5.6 interactive review，中修，5.14提交全部审稿意见，5.24三个审稿人全部endorsed，神奇的事情来了，5.13 编辑撂挑子不干了，找新编辑倒是挺快，5.23换了个大佬，但是新编辑不知道在干嘛，愣是拖了一个月，狂发邮件催，6.24编辑部介入，6.24 accepted,现在在等proof。所以说还是要多催催，编辑和编辑部一起催才有效果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cea5534804, createdName=DonAlexander, createdTime=Sat Jun 26 17:46:40 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑<br>7.13 Reviewer 1 is finalized.5555<br>7.26 Reviewer 2审完以后退出审稿3222<br>8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322<br>现在在第4个审稿人手里<br>这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192389, encodeId=d0bd1192389bc, content=偏重的研究方向：卒中;脑卒中<br>经验分享：之前审稿人1拒绝，审稿人3同意，审稿人2没做最终决定，然后编辑给了我时间大修，提交修改后，现在审稿人2也endorse了，希望大不，各位大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=周云祥, createdTime=Fri Feb 11 17:12:07 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101333, encodeId=5b8f2101333e0, content=什么时候中科院分区能到2区就好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJElIu4hBWdtKsL8e4OMFX4blMPokTQfJmF9xxjj6icsFK3wjhEtUYhh32DcBtw9jbEldHI9Yl5icoA/132, createdBy=f7322516953, createdName=钧钧, createdTime=Fri Nov 18 14:22:43 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. <br>09 May 2022 Review of Reviewer 4 is finalized. <br>05 May 2022 Interactive review forum activated automatically. <br>01 May 2022 Review of Reviewer 2 is finalized. <br>27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060422, encodeId=303f1060422b9, content=投的frontiers in oncology 洗个澡，后编辑让转投frontiers in neurology ，请问这个杂志好中吗，速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/18/3624dd53d07dd836b207284f6fb6cc08.jpg, createdBy=b9932459487, createdName=1241475am06暂无昵称, createdTime=Thu Oct 14 12:24:41 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813438, encodeId=913e81343879, content=第一次大修后，审稿人二同意发表，审稿人一不同意（而且语气说的很强硬），又给了一个礼拜让修改，修改完过了16天了，还没信，是不是要完了啊，哭死了！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42985413445, createdName=ms7000000171990402, createdTime=Wed Aug 26 15:03:57 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224799, encodeId=39841224e99d4, content=一审，审稿人3endorse，审稿人1和审稿人2让修改，修回去10天了，审稿人1回复修改挺满意，但没给finalized，审稿人2一直没回复，焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45895697468, createdName=ms8000001636492834, createdTime=Mon Jun 06 19:26:12 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588861, encodeId=cad8588861f8, content=3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回 目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]
    2020-08-26 ms7000000171990402

    第一次大修后，审稿人二同意发表，审稿人一不同意（而且语气说的很强硬），又给了一个礼拜让修改，修改完过了16天了，还没信，是不是要完了啊，哭死了！！！

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1189945, encodeId=0d42118994528, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：stroke<br>经验分享：2021年12月中旬就已经review finalized了，最后提交完修改意见，一直处于editor is evaluating阶段，毫无进展，中间发过一次邮件，编辑没有回，怎么办阿？需要给总编辑部发邮件问问嘛，希望有经验的朋友支个招，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e385414305, createdName=ms1000001473869572, createdTime=Thu Feb 03 17:08:56 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977098, encodeId=ae289e7098cd, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>经验分享：2.20投稿，找编辑找了2个礼拜，5.6 interactive review，中修，5.14提交全部审稿意见，5.24三个审稿人全部endorsed，神奇的事情来了，5.13 编辑撂挑子不干了，找新编辑倒是挺快，5.23换了个大佬，但是新编辑不知道在干嘛，愣是拖了一个月，狂发邮件催，6.24编辑部介入，6.24 accepted,现在在等proof。所以说还是要多催催，编辑和编辑部一起催才有效果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cea5534804, createdName=DonAlexander, createdTime=Sat Jun 26 17:46:40 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑<br>7.13 Reviewer 1 is finalized.5555<br>7.26 Reviewer 2审完以后退出审稿3222<br>8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322<br>现在在第4个审稿人手里<br>这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192389, encodeId=d0bd1192389bc, content=偏重的研究方向：卒中;脑卒中<br>经验分享：之前审稿人1拒绝，审稿人3同意，审稿人2没做最终决定，然后编辑给了我时间大修，提交修改后，现在审稿人2也endorse了，希望大不，各位大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=周云祥, createdTime=Fri Feb 11 17:12:07 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101333, encodeId=5b8f2101333e0, content=什么时候中科院分区能到2区就好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJElIu4hBWdtKsL8e4OMFX4blMPokTQfJmF9xxjj6icsFK3wjhEtUYhh32DcBtw9jbEldHI9Yl5icoA/132, createdBy=f7322516953, createdName=钧钧, createdTime=Fri Nov 18 14:22:43 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. <br>09 May 2022 Review of Reviewer 4 is finalized. <br>05 May 2022 Interactive review forum activated automatically. <br>01 May 2022 Review of Reviewer 2 is finalized. <br>27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060422, encodeId=303f1060422b9, content=投的frontiers in oncology 洗个澡，后编辑让转投frontiers in neurology ，请问这个杂志好中吗，速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/18/3624dd53d07dd836b207284f6fb6cc08.jpg, createdBy=b9932459487, createdName=1241475am06暂无昵称, createdTime=Thu Oct 14 12:24:41 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813438, encodeId=913e81343879, content=第一次大修后，审稿人二同意发表，审稿人一不同意（而且语气说的很强硬），又给了一个礼拜让修改，修改完过了16天了，还没信，是不是要完了啊，哭死了！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42985413445, createdName=ms7000000171990402, createdTime=Wed Aug 26 15:03:57 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224799, encodeId=39841224e99d4, content=一审，审稿人3endorse，审稿人1和审稿人2让修改，修回去10天了，审稿人1回复修改挺满意，但没给finalized，审稿人2一直没回复，焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45895697468, createdName=ms8000001636492834, createdTime=Mon Jun 06 19:26:12 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588861, encodeId=cad8588861f8, content=3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回 目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]
    2022-06-06 ms8000001636492834

    一审，审稿人3endorse，审稿人1和审稿人2让修改，修回去10天了，审稿人1回复修改挺满意，但没给finalized，审稿人2一直没回复，焦虑

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1189945, encodeId=0d42118994528, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：stroke<br>经验分享：2021年12月中旬就已经review finalized了，最后提交完修改意见，一直处于editor is evaluating阶段，毫无进展，中间发过一次邮件，编辑没有回，怎么办阿？需要给总编辑部发邮件问问嘛，希望有经验的朋友支个招，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e385414305, createdName=ms1000001473869572, createdTime=Thu Feb 03 17:08:56 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977098, encodeId=ae289e7098cd, content=审稿速度:6.0 | 投稿命中率:75.0 | 版面费用:2950.0<br>经验分享：2.20投稿，找编辑找了2个礼拜，5.6 interactive review，中修，5.14提交全部审稿意见，5.24三个审稿人全部endorsed，神奇的事情来了，5.13 编辑撂挑子不干了，找新编辑倒是挺快，5.23换了个大佬，但是新编辑不知道在干嘛，愣是拖了一个月，狂发邮件催，6.24编辑部介入，6.24 accepted,现在在等proof。所以说还是要多催催，编辑和编辑部一起催才有效果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cea5534804, createdName=DonAlexander, createdTime=Sat Jun 26 17:46:40 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239795, encodeId=801c1239e9550, content=7.6分配编辑<br>7.13 Reviewer 1 is finalized.5555<br>7.26 Reviewer 2审完以后退出审稿3222<br>8.18 Reviewer 3审完，提了一些问题，让修改后发表，分数3322<br>现在在第4个审稿人手里<br>这啥情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b35487381, createdName=Yhao, createdTime=Fri Aug 19 19:01:00 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192389, encodeId=d0bd1192389bc, content=偏重的研究方向：卒中;脑卒中<br>经验分享：之前审稿人1拒绝，审稿人3同意，审稿人2没做最终决定，然后编辑给了我时间大修，提交修改后，现在审稿人2也endorse了，希望大不，各位大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54f25602667, createdName=周云祥, createdTime=Fri Feb 11 17:12:07 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101333, encodeId=5b8f2101333e0, content=什么时候中科院分区能到2区就好了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJElIu4hBWdtKsL8e4OMFX4blMPokTQfJmF9xxjj6icsFK3wjhEtUYhh32DcBtw9jbEldHI9Yl5icoA/132, createdBy=f7322516953, createdName=钧钧, createdTime=Fri Nov 18 14:22:43 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220563, encodeId=bceb1220563fb, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：16 May 2022 Article accepted for publication.Review of Review Editor 1 finalized.Corresponding Author re-submitted manuscript.You posted new comments.You posted new comments. <br>09 May 2022 Review of Reviewer 4 is finalized. <br>05 May 2022 Interactive review forum activated automatically. <br>01 May 2022 Review of Reviewer 2 is finalized. <br>27 Apr 2022 Corresponding Author submitted manuscript. 这次审稿速度很快，20天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue May 17 22:58:14 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060422, encodeId=303f1060422b9, content=投的frontiers in oncology 洗个澡，后编辑让转投frontiers in neurology ，请问这个杂志好中吗，速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/18/3624dd53d07dd836b207284f6fb6cc08.jpg, createdBy=b9932459487, createdName=1241475am06暂无昵称, createdTime=Thu Oct 14 12:24:41 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813438, encodeId=913e81343879, content=第一次大修后，审稿人二同意发表，审稿人一不同意（而且语气说的很强硬），又给了一个礼拜让修改，修改完过了16天了，还没信，是不是要完了啊，哭死了！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42985413445, createdName=ms7000000171990402, createdTime=Wed Aug 26 15:03:57 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224799, encodeId=39841224e99d4, content=一审，审稿人3endorse，审稿人1和审稿人2让修改，修回去10天了，审稿人1回复修改挺满意，但没给finalized，审稿人2一直没回复，焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45895697468, createdName=ms8000001636492834, createdTime=Mon Jun 06 19:26:12 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588861, encodeId=cad8588861f8, content=3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回 目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicNxaibzicFd3zQMibV0sw9miaRu5RAPg2QncI2aFOzIsAPqHklCxrR7nSQE8Q7wUbopkgdEQK7K7kTQ/132, createdBy=5f995124551, createdName=Riverswide, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]
    2020-04-14 Riverswide

    3.27投稿 3.30editor assignment 当天independent review 4.8interactive review 4.11修回 4.11reviewer1 同意录用 4.13reviewer2新加了一些小意见 4.14修回 目前等待中

    4

    展开4条回复
共230条页码: 1/23页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分